Her primary scientific interests are in Breast cancer, Internal medicine, Gynecology, Relative risk and Oncology. The various areas that Catherine Schairer examines in her Breast cancer study include Menopause, Estrogen, Risk factor and Obstetrics. Many of her studies involve connections with topics such as Endocrinology and Internal medicine.
Her research investigates the connection between Gynecology and topics such as Lower risk that intersect with problems in Smoking cessation. Her studies deal with areas such as Attributable risk, Absolute risk reduction and Breast biopsy as well as Relative risk. Her Oncology research is multidisciplinary, incorporating perspectives in Endometrial cancer and Adenocarcinoma.
Her scientific interests lie mostly in Internal medicine, Breast cancer, Oncology, Cancer and Gynecology. Her work in Internal medicine is not limited to one particular discipline; it also encompasses Endocrinology. The concepts of her Breast cancer study are interwoven with issues in Epidemiology, Relative risk, Obstetrics, Estrogen and Risk factor.
Her Relative risk research is multidisciplinary, incorporating elements of Attributable risk and Mammography. Her Oncology research also works with subjects such as
Catherine Schairer spends much of her time researching Internal medicine, Breast cancer, Oncology, Cancer and Odds ratio. Her Internal medicine research focuses on Diabetes mellitus and how it connects with Obesity. She works in the field of Breast cancer, focusing on Inflammatory breast cancer in particular.
The Oncology study which covers Meta-analysis that intersects with Body mass index, Epidemiology of cancer and Menopausal hormone therapy. She has researched Prospective cohort study in several fields, including Ovary, Ovarian cancer, Fallopian tube and Risk factor. Gynecology is closely connected to Etiology in her research, which is encompassed under the umbrella topic of Family history.
Catherine Schairer mainly investigates Internal medicine, Oncology, Breast cancer, Epidemiology and Meta-analysis. Her study in Body mass index, Prospective cohort study, Odds ratio, Hepatocellular carcinoma and Cancer is done as part of Internal medicine. Her Body mass index study integrates concerns from other disciplines, such as Gallbladder cancer and Risk factor.
Her Prospective cohort study research focuses on subjects like Confidence interval, which are linked to Case-control study and Cohort study. Her research investigates the link between Oncology and topics such as Diabetes mellitus that cross with problems in Gynecology. Catherine Schairer combines subjects such as Overweight, Epidemiology of cancer, Menopausal hormone therapy, Aspirin and Endometrial cancer with her study of Epidemiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually
Mitchell H. Gail;Louise A. Brinton;David P. Byar;Donald K. Corle.
Journal of the National Cancer Institute (1989)
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
E. E. Calle;C. W. Heath;R. J. Coates;J. M. Liff.
The Lancet (1997)
Breast cancer and hormonal contraceptives : collaborative reanalysis of individual data on 53.297 women with breast cancer and 100.239 women without breast cancer from 54 epidemiological studies
E. E. Calle;C. W. Heath;H. L. Miracle-McMahill;R. J. Coates.
The Lancet (1996)
ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK FACTORS USING CASE-CONTROL DATA
Paolo Bruzzi;Sylvan B. Green;David P. Byar;Louise A. Brinton.
American Journal of Epidemiology (1985)
Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
Catherine Schairer;Jay Lubin;Rebecca Troisi;Susan Sturgeon.
JAMA (2000)
Alcohol, tobacco and breast cancer - Collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease
N Hamajima;K Hirose;K Tajima;T Rohan.
British Journal of Cancer (2002)
Mammographic Features and Breast Cancer Risk: Effects With Time, Age, and Menopause Status
Celia Byrne;Catherine Schairer;John Wolfe;Navin Parekh.
Journal of the National Cancer Institute (1995)
Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults
Steven C. Moore;I-Min Lee;Elisabete Weiderpass;Peter T. Campbell.
JAMA Internal Medicine (2016)
The risk of breast cancer after estrogen and estrogen-progestin replacement.
LElF Bergkvist;Hans-Olgy Adami;Ingemar Persson;Robert Hoover.
The New England Journal of Medicine (1989)
Menopausal hormone replacement therapy and risk of ovarian cancer.
James V. Lacey;Pamela J. Mink;Jay H. Lubin;Mark E. Sherman.
JAMA (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
National Institutes of Health
Brigham and Women's Hospital
Harvard Medical School
Karolinska Institutet
Harvard University
National Institutes of Health
American Cancer Society
National Institutes of Health
Karolinska Institute
Aalborg University
University of Granada
Northwestern University
Helmholtz Centre for Environmental Research
Instituto de Salud Carlos III
University of Lausanne
Baylor College of Medicine
Institute of Tropical Medicine Antwerp
Space Science Institute
Oxford Brookes University
Environment and Climate Change Canada
Johns Hopkins University
University of Manchester
Hebrew University of Jerusalem
Washington State University
UK Astronomy Technology Centre